ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,064.20
0.91%
US Tech 100
17,076.00
0.00%
다우존스 지수
38,225.66
0.85%
Bitcoin
59,395.53
0.46%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE
  6. Addex Therapeutics Ltd (0QNV)

  7. Addex Therapeutics Ltd (0QNV) 뉴스

0QNV Addex Therapeutics Ltd

3.02
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Addex Therapeutics Ltd 0QNV 런던 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 3.02 09:00:00
개장가 저가 고가 종가 전일 종가
3.02
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202414:00UKREGAddex Provides Update on ADX71149 Phase 2 Epilepsy Study
19/04/202414:00UKREGAddex to Present at the Swiss Biotech Day 2024
18/04/202414:00UKREGAddex Therapeutics Reports Full Year 2023 Financial Results..
11/04/202414:00UKREGAddex Therapeutics to Release Full-Year 2023 Financial..
03/04/202414:00UKREGAddex and Perceptive Launch Neurosterix with $63 Million to..
14/03/202415:00UKREGAddex to Present at the Bio-Europe Spring 2024 Conference
31/01/202415:00UKREGAddex Enters into At-The-Market ADS Offering Agreement with..
09/01/202415:00GLOBEAddex to Present at the Swiss Equities Baader Conference
05/01/202415:30GLOBEAddex to Present at Biotech Showcase™ 2024
20/12/202315:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
14/12/202315:00GLOBEAddex Creates Treasury Shares
29/11/202315:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
28/11/202315:00GLOBEAddex Convenes Extraordinary General Meeting
23/11/202315:00GLOBEAddex Therapeutics to Release Third Quarter 2023 Financial..
14/11/202315:00GLOBEAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
08/11/202315:00GLOBEAddex Regains Nasdaq Listing Compliance
02/11/202315:00GLOBEAddex Announces Participation in the Bio-Europe 2023..
20/10/202314:00GLOBEAddex Completes ADS Ratio Change
07/10/202305:00GLOBEAddex Announces Plan to Implement ADS Ratio Change
20/09/202314:00GLOBEAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
06/09/202314:00GLOBEAddex Announces Participation in the H.C. Wainwright 25th..
05/09/202314:00GLOBEAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
04/09/202314:00GLOBEAddex’s Dipraglurant Development in Post-Stroke Recovery..
10/08/202314:00GLOBEAddex Reports 2023 Half Year and Second Quarter Financial..
04/08/202314:00GLOBEAddex Therapeutics to Release Half-Year 2023 Financial..
03/08/202314:00GLOBEAddex GABAB Positive Allosteric Modulator Program to Receive..
24/07/202314:00GLOBEAddex mGlu2PAM Demonstrates Potential in Substance Use..
15/06/202314:00GLOBEAddex Increases Issued Share Capital to Create Treasury..
01/06/202314:00GLOBEAddex Shareholders Approve All Resolutions at Annual General..
18/05/202314:00GLOBEAddex Receives Nasdaq Notification Regarding Minimum Bid..
11/05/202314:00GLOBEAddex Reports Q1 2023 Financial Results and Provides..
10/05/202314:00GLOBEAddex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s..
05/05/202314:00GLOBEAddex Convenes Annual General Meeting 2023
04/05/202314:00GLOBEAddex Therapeutics to Release Q1 2023 Financial Results and..

최근 히스토리

LSE
0QNV
Addex Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유